Award recordCONTRACT

BECKMAN COULTER, INC

PIID VA26117F1557· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6630 · CHEMICAL ANALYSIS INSTRUMENTS· FY2017· $2,072,872 net obligations· UEI PU6HHX2R11C7· CA

Description

OBLIGATION INCREASE TO ALLOW CLOSEOUT

Base award description: CHEMISTRY&IMMUNOASSAY CPRR - VISN 21

First action · last action
2017-03-28 · 2023-03-30
Transactions
13
First transaction's obligation
$154,687
Base + all options value (sum of deltas)
$2,248,308
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
4
SDVOSB flag on record
No
Parent IDV
V797P7090A
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING

Modification chain · 13 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$2,072,872$0Base award · 2017-03-28 · this action $154,687 · running total $154,687Modification P00001 · 2017-10-01 · this action $309,375 · running total $464,062Modification P00002 · 2018-04-30 · this action $47,847 · running total $511,909Modification P00003 · 2018-10-01 · this action $309,375 · running total $821,284Modification P00004 · 2018-11-08 · this action $133,939 · running total $955,223Modification P00005 · 2019-10-01 · this action $309,375 · running total $1,264,598Modification P00006 · 2019-12-18 · this action $81,813 · running total $1,346,411Modification P00007 · 2020-10-01 · this action $309,375 · running total $1,655,786Modification P00008 · 2021-06-10 · this action $23,022 · running total $1,678,807Modification P00009 · 2021-10-01 · this action $154,687 · running total $1,833,494Modification P00010 · 2022-03-31 · this action $180,000 · running total $2,013,494Modification P00011 · 2022-07-19 · this action $30,941 · running total $2,044,436Modification P00012 · 2023-03-30 · this action $28,437 · running total $2,072,872
  • Base2017-03-28+$154,687= $154,687
  • Mod P000012017-10-01+$309,375= $464,062
  • Mod P000022018-04-30+$47,847= $511,909
  • Mod P000032018-10-01+$309,375= $821,284
  • Mod P000042018-11-08+$133,939= $955,223
  • Mod P000052019-10-01+$309,375= $1,264,598
  • Mod P000062019-12-18+$81,813= $1,346,411
  • Mod P000072020-10-01+$309,375= $1,655,786
  • Mod P000082021-06-10+$23,022= $1,678,807
  • Mod P000092021-10-01+$154,687= $1,833,494
  • Mod P000102022-03-31+$180,000= $2,013,494
  • Mod P000112022-07-19+$30,941= $2,044,436
  • Mod P000122023-03-30+$28,437= $2,072,872
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-03-28+$154,687$154,687CHEMISTRY&IMMUNOASSAY CPRR - VISN 21
Mod P00001· EXERCISE AN OPTION2017-10-01+$309,375$464,062CHEMISTRY&IMMUNOASSAY CPRR - VISN 21
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2018-04-30+$47,847$511,909INCREASE IN TESTS PER MONTH FOR CHEMISTRY&IMMUNOASSAY CPRR - VISN 21
Mod P00003· EXERCISE AN OPTION2018-10-01+$309,375$821,284INCREASE IN TESTS PER MONTH FOR CHEMISTRY&IMMUNOASSAY CPRR - VISN 21
Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2018-11-08+$133,939$955,223ADD FUNDS
Mod P00005· EXERCISE AN OPTION2019-10-01+$309,375$1,264,598ADD FUNDS
Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2019-12-18+$81,813$1,346,411ADD FUNDS
Mod P00007· EXERCISE AN OPTION2020-10-01+$309,375$1,655,786ADD FUNDS
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-06-10+$23,022$1,678,807ADD FUNDS
Mod P00009· EXERCISE AN OPTION2021-10-01+$154,687$1,833,494ADD FUNDS
Mod P00010· EXERCISE AN OPTION2022-03-31+$180,000$2,013,4946 MONTH EXTENSION
Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-07-19+$30,941$2,044,4366 MONTH EXTENSION
Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-03-30+$28,437$2,072,872OBLIGATION INCREASE TO ALLOW CLOSEOUT

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI PU6HHX2R11C7)

AwardOffice · PSC / listingNet obligationsFY
36C26226N0869262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$111,853FY2026
36C25726N0476257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$1,450,556FY2026
36C25926N0424NETWORK CONTRACT OFFICE 19 (36C259) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS$2,989,154FY2026
36C25726N0456257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$365,580FY2026
36C24426N0923244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING$84,816FY2026
36C24426N0922244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING$46,600FY2026

Other recipients under 6630 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126F0309BIOMERIEUX INC261-NETWORK CONTRACT OFFICE 21 (36C261)$360,089FY2026
36C26126N0375BIOMERIEUX INC261-NETWORK CONTRACT OFFICE 21 (36C261)$136,706FY2026
36C26126N0135POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$37,831FY2026
36C26126F0020BIOMERIEUX INC261-NETWORK CONTRACT OFFICE 21 (36C261)$278,149FY2026
36C26126N0078ORTHO-CLINICAL DIAGNOSTICS, INC261-NETWORK CONTRACT OFFICE 21 (36C261)$154,375FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26117F1557_3600_V797P7090A_3600 · retrieved 2026-09-26.